|
Q3 FY2026
As of Jun 30, 2026
|
Q2 FY2026
As of Mar 31, 2026
|
Q1 FY2026
As of Dec 31, 2025
|
Q4 FY2025
As of Sep 30, 2025
|
Q3 FY2025
As of Jun 30, 2025
|
Q2 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash | ||||||
| Prepaid expenses | ||||||
| Deferred Offering Cost | ||||||
| Accounts receivable and other receivables | ||||||
| Total current assets | ||||||
| Advance Payment | ||||||
| Intangible assets, net | ||||||
| Prepaid development costs | ||||||
| Internally developed software WIP | ||||||
| Property acquisition deposit | ||||||
| Property and equipment, net | ||||||
| Deferred offering costs | ||||||
| Total Assets | ||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||
| Current Liabilities | ||||||
| Payables and accrued liabilities | ||||||
| Tax payable | ||||||
| Accounts payables | ||||||
| Accrued liabilities | ||||||
| Due to related parties | ||||||
| Loan payable | ||||||
| Contract liabilities | ||||||
| Total current liabilities | ||||||
| Note payable, net | ||||||
| Accrued interest payable | ||||||
| Total Liabilities | ||||||
| Stockholders’ Equity | ||||||
| Common stock, $0.001 par value, 50,000,000 and 50,000,000 shares authorized, 12,147,230 and 12,101,273 shares issued and outstanding at June 30, 2026 and September 30, 2025, respectively | ||||||
| Additional paid-in capital | ||||||
| Accumulated deficit | ||||||
| Total stockholders’ equity | ||||||
| Total liabilities and stockholders’ equity |
Loading...
